NCT04397692View on ClinicalTrials.gov

Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial)

NATerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

June 13, 2020

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Corona Virus InfectionCOVID-19SARS-CoV 2Nitric OxideRespiratory DiseasePneumonia, ViralInhaled Nitric Oxide
Interventions
DEVICE

Nitric Oxide delivered via LungFit™ system

Patients will receive inhalations of 80 ppm for 40 min 4 times a day

Trial Locations (1)

72205

Baptist Health Center for Clinical Research, Little Rock

Sponsors

Lead Sponsor

Beyond Air Inc.
All Listed Sponsors
lead

Beyond Air Inc.

INDUSTRY